PEMBROLIZUMAB

pembrolizumab 100 mg/4 mL injection, 4 mL vial

PEMBROLIZUMAB (15299F)

pembrolizumab 100 mg/4 mL injection, 4 mL vial
15299F
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required (STREAMLINED)

Restriction  18371

Indication: High risk locally advanced carcinoma of the cervix
Treatment phase: Initial treatment

Restriction  18450

Indication: High risk locally advanced carcinoma of the cervix
Treatment phase: Continuing treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 400 mg # of repeats: 7 DPMA: $14,870.58 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Keytruda
(pembrolizumab 100 mg/4 mL injection, 4 mL vial)